Literature DB >> 11430617

Treatment of anxiety disorders to remission.

J C Ballenger1.   

Abstract

Treating anxiety disorders to remission should be the goal of all practitioners. A remitted patient should be well, both in symptoms and function, and be indistinguishable from a never-ill counterpart. The definition of remission in patients with anxiety disorders should also be clear, practical, and easy to use. It is useful to measure response in an objective way, such as with standardized instruments appropriate for the disorder, and to develop remission criteria specific to each disorder. This article proposes remission criteria, using standardized measures, for 5 common anxiety disorders: panic disorder, social anxiety disorder, generalized anxiety disorder, obsessive-compulsive disorder, and post-traumatic stress disorder.

Entities:  

Mesh:

Year:  2001        PMID: 11430617

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  11 in total

1.  Algorithm for the pharmacotherapy of anxiety disorders.

Authors:  Dan J Stein
Journal:  Curr Psychiatry Rep       Date:  2003-08       Impact factor: 5.285

Review 2.  Social anxiety disorder : current treatment recommendations.

Authors:  Jacqueline E Muller; Liezl Koen; Soraya Seedat; Dan J Stein
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

3.  Estrogen receptor beta expression in the embryonic brain regulates development of calretinin-immunoreactive GABAergic interneurons.

Authors:  Xiaotang Fan; Margaret Warner; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-11       Impact factor: 11.205

Review 4.  Current considerations in the treatment of generalized anxiety disorder.

Authors:  Martin A Katzman
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

5.  Effective Recognition and Treatment of Generalized Anxiety Disorder in Primary Care.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

6.  Medication dependence and anxiety.

Authors:  Lisa L von Moltke; David J Greenblatt
Journal:  Dialogues Clin Neurosci       Date:  2003-09       Impact factor: 5.986

7.  Pharmacological management of panic disorder.

Authors:  Carlo Marchesi
Journal:  Neuropsychiatr Dis Treat       Date:  2008-02       Impact factor: 2.570

8.  Venlafaxine in the treatment of panic disorder.

Authors:  Martin A Katzman; Leslie Jacobs
Journal:  Neuropsychiatr Dis Treat       Date:  2007-02       Impact factor: 2.570

9.  Venlafaxine extended release (XR) in the treatment of panic disorder.

Authors:  Kevin Kjernisted; Diane McIntosh
Journal:  Ther Clin Risk Manag       Date:  2007-03       Impact factor: 2.423

10.  Factors associated with treatment outcomes in mindfulness-based cognitive therapy for panic disorder.

Authors:  Borah Kim; Sung Joon Cho; Kang Soo Lee; Jun-Yeob Lee; Ah Young Choe; Ji Eun Lee; Tai Kiu Choi; Sang-Hyuk Lee
Journal:  Yonsei Med J       Date:  2013-11       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.